The buzz around cannabis products is understandable. But we simply don't know enough yet about possible benefits — or risks.
By Timothy Caulfield,
In order to survive wearing high heels at the Oscars this year, Melissa McCarthy put a dab of CBD oil between her toes. Both US Magazine and Women’s Health called the move “genius!”
Over
the course of several decades, cannabis products have gone from
something that could lead to “murder, insanity and death,” as a 1935 government warning declared, to a highly sought-after wellness product. The justifications for the past demonization of cannabis
are both historically complex and often irrational. So, to some degree,
the pendulum swing from risk to benefit makes sense and is a welcome
change. Still, the totality of the cultural shift in the framing of
cannabis is dramatic.
Big picture, I think marijuana legalization
is a good idea. It will help control consumption, particularly among
the young, and allow for useful research and, eventually, biomedical
applications.
But I also think that the current hype surrounding cannabis is problematic, and this includes all the emerging products derived from cannabis.
The current hype surrounding cannabis products is problematic, and this includes all the emerging products derived from cannabis.
Most of the cannabis-focused wellness products contain cannabidiol, commonly referred to as CBD.
This is a cannabis extract that does not contain the buzz-inducing THC.
Almost overnight, CBD is absolutely everywhere. It is often portrayed
as some kind of cure-all. There are CBD-infused shampoos, toothpastes, lotions and soaps. CBD is being used and promoted by professional athletes as a way to facilitate recovery and as an anti-aging compound.
You can get CBD supplements for both your dog (to help with “separation anxiety” and “fear of fireworks and thunder”) and your cat (because anxiety is the “most under-diagnosed condition affecting cats” — at least, according to this enterprising vet.) Soon you will be able to turn to none other than Martha Stewart
— a name not often associated in the past with bongs and dime bags — to
purchase your pet’s pot pills. She recently partnered with Canopy Grow, one of the world’s largest legal cannabis producers, to create a line of “sensible products for people’s beloved pets.”
Cannabis is, of course, also being marketed for a range of more serious health issues, including childhood ADHD, autism, anxiety and, perhaps most frequently, pain.
As I said, it is everywhere. It has been estimated that the CBD market will be worth approximately $22 billion by 2022.
But
despite all the positive press, money and pop culture noise, the
science remains pretty foggy.
There is no doubt that CBD is an
interesting compound. And the liberalization of the laws in many
jurisdictions throughout the world is leading to a lot of intriguing research on the plant. To date, however, there is little or no evidence to support the vast majority of the wellness and performance
claims we are seeing in pop culture. As noted by the World Health
Organization in a 2018 review of CBD: “for most indications, there is
only pre-clinical evidence.” In other words, there aren’t a lot of
studies involving humans.
My friend and University of British Columbia pharmacy professor, James McCormack,
summarized the state of the science thus: “There are lots of people who
claim CBD improves numerous medical issues and symptoms. However, while
there is reasonable evidence (well designed placebo controlled trials)
for a few conditions (such as intractable seizures in children) the
highest level of evidence for most conditions is just anecdotes. We need
a lot more well-designed clinical studies.”
There are a number of interesting social trends feeding this love affair with all-things cannabis.
This near complete lack of good clinical evidence hasn’t slowed the momentum of the hype, of CBD or marijuana more generally. Recent research
found that almost all of news coverage about cannabis “communicates a
more positive message than is warranted by current evidence.” A study by
the group Health Feedback
— a collection of biomedical academics that assess the credibility of
news stories — found that the top social media story of 2018 was one
that claimed marijuana was one hundred times less toxic than alcohol. A
claim that is, at best, a hefty exaggeration.
There are a
number of interesting social trends feeding this love affair with
all-things cannabis.
Because it is perceived as “natural” (an odd
classification given that it is a chemical like any pharmaceutical
products) it fits perfectly with the ethos of the burgeoning wellness
industry.
Many proprietors of cannabis products, including a growing list of alternative practitioners, present them as a natural and/or organic alternative — which, as we know from research in other domains, can help to sell a lot of product and create a strong and persuasive health halo. If it is natural, it must be better!
In
addition, purchasing a cannabis product still comes with a bit of
ideological cache. Cannabis is, or so its proponents want us to believe,
the anti-Big Pharma drug of choice. Its secret benefits have been
hidden from the masses by a number of nefarious players, most notably
the biomedical industrial complex (or so the story goes). “News” websites like Natural News
have played to this intuitively appealing narrative with headlines that
declare, “Big Pharma and the government are suppressing marijuana's
medicinal benefits.” This kind of messaging adds to the allure of
cannabis and allows it to maintain a smidge of counter-culture cred,
even if your cat is dabbling in the same products.
(In reality, pharmaceutical companies are also getting into the cannabis game.)
And,
of course, celebrities have also played a big role. Melissa McCarthy’s
CBD toe therapy was reported in the press as a logical application of an
emerging therapy. No scientific proof required.
Why is all this hype concerning? Much of it is straight up misleading marketing that can generate inaccurate and harmful public perceptions.
Why is all this hype concerning? Much of it is straight up misleading marketing that can generate inaccurate and harmful public perceptions. As noted in a recent statement from the FDA
about questionable cannabis products: “deceptive marketing of unproven
treatments raises significant public health concerns,” including the
potential to “keep some patients from accessing appropriate, recognized
therapies.”
All this positive press might also lead people to overlook the possible risks associated with cannabis products. One study, for example, found that the positive portrayals of the health applications of cannabis have an impact on the perception of recreational use. And while the emerging evidence suggests that CBD is well tolerated, we need to recognize that we don’t have a lot of safety data, particularly in the context of long-term use.
The
buzz around cannabis is understandable. I am hopeful that in the
relatively near future we will know much more about benefits and risks.
But we aren’t there yet. For now, you can ignore most of the cannabis
noise, whether you are thinking about something for your tension, toes
or our tabby.
No comments:
Post a Comment